Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta
Clinical trial NCT04545554 · COMPLETED
Trial details
- NCT number
- NCT04545554
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-21
- Primary completion
- 2023-03-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.